Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies

ConclusionsRegardless of baseline itch severity, IXE treatment provided a rapid improvement in itch followed by clinically meaningful improvements in psoriasis.FundingEli Lilly and Company.Trial registrationClinicalTrials.gov identifiers, NCT01597245 and NCT01646177.

http://link.springer.com/10.1007/s13555-018-0267-9

Source: Dermatology and Therapy - November 21, 2018 Category: Dermatology Source Type: research